Prentiss Smith & Co’s Pfizer PFE Stock Holding History

Prentiss Smith & Co’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$369K	Hold	15,327	–	–	0.2%	58
2026 Q1	$430K	Hold	15,327	–	–	0.25%	52
2025 Q4	$382K	Hold	15,327	–	–	0.23%	56
2025 Q3	$391K	Sell	15,327 -500	-3%	-$12.3K	0.22%	59
2025 Q2	$384K	Hold	15,827	–	–	0.23%	56
2025 Q1	$401K	Hold	15,827	–	–	0.26%	54
2024 Q4	$420K	Hold	15,827	–	–	0.27%	52
2024 Q3	$458K	Hold	15,827	–	–	0.29%	50
2024 Q2	$443K	Hold	15,827	–	–	0.31%	48
2024 Q1	$439K	Sell	15,827 -1,496	-9%	-$41.5K	0.31%	49
2023 Q4	$499K	Sell	17,323 -500	-3%	-$15.1K	0.37%	46
2023 Q3	$591K	Sell	17,823 -269	-1%	-$9.51K	0.44%	43
2023 Q2	$664K	Hold	18,092	–	–	0.5%	40
2023 Q1	$738K	Buy	18,092 +944	+6%	+$40.8K	0.55%	41
2022 Q4	$879K	Sell	17,148 -4	-0%	-$192	0.8%	27
2022 Q3	$751K	Hold	17,152	–	–	0.67%	36
2022 Q2	$899K	Sell	17,152 -500	-3%	-$25.5K	0.69%	35
2022 Q1	$914K	Hold	17,652	–	–	0.55%	39
2021 Q4	$1.04M	Buy	17,652 +2,000	+13%	+$99.1K	0.49%	44
2021 Q3	$673K	Buy	15,652 +1,022	+7%	+$45.3K	0.34%	48
2021 Q2	$573K	Sell	14,630 -779	-5%	-$30.3K	0.28%	53
2021 Q1	$558K	Hold	15,409	–	–	0.29%	54
2020 Q4	$567K	Sell	15,409 -1,364	-8%	-$50K	0.27%	51
2020 Q3	$584K	Buy	16,773 +5,733	+52%	+$201K	0.3%	46
2020 Q2	$342K	Sell	11,040 -347	-3%	-$11.8K	0.21%	52
2020 Q1	$353K	Sell	11,387 -1,723	-13%	-$58.7K	0.25%	51
2019 Q4	$487K	Sell	13,110 -744	-5%	-$26.5K	0.31%	45
2019 Q3	$472K	Buy	13,854 +5	+0%	+$182	0.32%	44
2019 Q2	$569K	Sell	13,849 -74	-0.5%	-$2.94K	0.37%	41
2019 Q1	$561K	Buy	13,923 +1,159	+9%	+$46.4K	0.36%	40
2018 Q4	$529K	Sell	12,764 -527	-4%	-$21.9K	0.33%	41
2018 Q3	$556K	Sell	13,291 -2,759	-17%	-$106K	0.32%	41
2018 Q2	$552K	Hold	16,050	–	–	0.33%	41
2018 Q1	$540K	Buy	16,050 +348	+2%	+$12K	0.28%	51
2017 Q4	$540K	Hold	15,702	–	–	0.26%	53
2017 Q3	$532K	Sell	15,702 -686	-4%	-$22K	0.31%	45
2017 Q2	$522K	Buy	16,388 +633	+4%	+$20K	0.27%	48
2017 Q1	$511K	Buy	15,755 +263	+2%	+$8.29K	0.29%	46
2016 Q4	$477K	Sell	15,492 -817	-5%	-$24.9K	0.29%	43
2016 Q3	$524K	Hold	16,309	–	–	0.29%	46
2016 Q2	$545K	Sell	16,309 -1,328	-8%	-$42.4K	0.31%	44
2016 Q1	$496K	Hold	17,637	–	–	0.29%	50
2015 Q4	$540K	Buy	17,637 +1,252	+8%	+$39.4K	0.29%	48
2015 Q3	$488K	Hold	16,385	–	–	0.27%	50
2015 Q2	$521K	Sell	16,385 -6,862	-30%	-$224K	0.26%	52
2015 Q1	$767K	Sell	23,247 -632	-3%	-$20.1K	0.37%	41
2014 Q4	$706K	Buy	23,879 +1,581	+7%	+$45.3K	0.33%	46
2014 Q3	$626K	Sell	22,298 -422	-2%	-$11.8K	0.31%	48
2014 Q2	$640K	Hold	22,720	–	–	0.33%	51
2014 Q1	$692K	Hold	22,720	–	–	0.37%	51
2013 Q4	$660K	Buy	22,720 +392	+2%	+$11.4K	0.35%	50
2013 Q3	$609K	Hold	22,328	–	–	0.32%	50
2013 Q2	$593K	Buy	+22,328	New	+$617K	0.31%	54

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Prentiss Smith & Co's PFE Position: Q2 2026 in Review

Prentiss Smith & Co held its Pfizer (PFE) position steady in Q2 2026 at 15,327 shares worth $369K. The position accounts for 0.2% of the portfolio, ranked #58.

Prentiss Smith & Co first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.04M in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Prentiss Smith & Co held 15,327 shares of Pfizer worth $369K as of Q2 2026.
Prentiss Smith & Co left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.2% of Prentiss Smith & Co's portfolio in Q2 2026, its #58 holding.
Prentiss Smith & Co first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
Prentiss Smith & Co's Pfizer position peaked at $1.04M in Q4 2021.
2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Prentiss Smith & Co's 13F filing for Q2 2026, filed 30 Jul 2026.